Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB378735

Inhibin alpha Antibody (INHA/6598R), DyLight 488, Novus Biologicals™
SDP

Catalog No. NB378735 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB378735 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB378735 Supplier Novus Biologicals Supplier No. NBP308782G
Only null left
Add to Cart
Add to Cart

Description

Rabbit Monoclonal Antibody

Inhibin alpha Monoclonal antibody specifically detects Inhibin alpha in Human samples. It is validated for Immunohistochemistry (Paraffin)

Specifications

Antigen Inhibin alpha
Applications Immunohistochemistry (Paraffin)
Classification Monoclonal
Clone INHA/6598R
Conjugate DyLight 488
Formulation 50mM Sodium Borate
Gene Alias A-inhibin subunit, INHA, inhibin alpha chain, inhibin, alpha
Host Species Rabbit
Immunogen Recombinant fragment of human Inhibin alpha protein (around aa 233-362) (exact sequence is proprietary) (Uniprot: P05111 )
Purification Method Protein A or G purified
Quantity 100 μg
Regulatory Status RUO
Research Discipline Apoptosis, Cancer
Primary or Secondary Primary
Gene ID (Entrez) 3623
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.